$342.39M
Revenue
$3.58M
Net Income
79.25%
Gross Margin
-0.25%
Op. Margin
$133.14M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Total Revenue | $342.39M | $342.39M | $367.25M |
| Revenue Growth % | 0.0% | -6.8% | nan% |
| Cost of Revenue | $71.06M | $71.06M | $50.12M |
| Gross Profit | $271.33M | $271.33M | $317.13M |
| Gross Margin % | 79.2% | 79.2% | 86.4% |
| Operating Expenses | $272.18M | $272.18M | $289.21M |
| Research & Development | $61.08M | $61.08M | $63.27M |
| Operating Income | $-841.00K | $-841.00K | $27.93M |
| Operating Margin % | -0.2% | -0.2% | 7.6% |
| Interest Expense | $617.00K | $500.00K | $3.60M |
| Other Income/Expense | $-93.00K | $-93.00K | $-3.16M |
| Income Before Tax | $9.85M | $9.85M | $24.50M |
| Income Tax Expense | $6.27M | $6.27M | $-44.25M |
| Net Income | $3.58M | $3.58M | $68.74M |
| Net Margin % | 1.0% | 1.0% | 18.7% |
| Basic EPS | 0.13 | 0.13 | 2.85 |
| Diluted EPS | 0.12 | 0.12 | 2.56 |
| Basic Shares Outstanding | - | 28.4M | 24.1M |
| Diluted Shares Outstanding | - | 30.1M | 26.9M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|
| Cash & Cash Equivalents | $186.61M | $349.28M |
| Accounts Receivable | $208.71M | $220.88M |
| Other Current Assets | $12.60M | $11.17M |
| Total Current Assets | $407.93M | $581.74M |
| Property Plant & Equipment | $23.43M | $1.95M |
| Other Non-current Assets | $1.08M | $794.00K |
| Total Assets | $525.91M | $678.43M |
| Accounts Payable | $10.84M | $7.16M |
| Accrued Liabilities | $19.61M | $17.96M |
| Other Current Liabilities | $1.25M | $6.09M |
| Total Current Liabilities | $207.76M | $204.16M |
| Long-term Debt | - | - |
| Other Non-current Liabilities | - | $16.98M |
| Total Liabilities | $238.26M | $221.15M |
| Common Stock | - | - |
| Retained Earnings | $-136.87M | $-140.45M |
| Total Stockholders Equity | $287.65M | $457.28M |
| Total Liabilities & Equity | $525.91M | $678.43M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
|---|---|---|---|
| Net Income | $4.13M | $3.58M | $68.74M |
| Depreciation & Amortization | $15.10M | $8.32M | $8.08M |
| Stock-based Compensation | $78.78M | $44.14M | $46.92M |
| Deferred Income Tax | - | $3.15M | $-53.62M |
| Change in Receivables | $-35.01M | $-10.24M | $-4.40M |
| Change in Payables | $1.75M | $355.00K | $-911.00K |
| Operating Cash Flow | $160.85M | $95.27M | $115.92M |
| Capital Expenditure | $27.71M | $20.29M | $871.00K |
| Investing Cash Flow | $-51.24M | $-34.30M | $-10.20M |
| Stock Issued | - | - | $2.79M |
| Stock Repurchased | $442.93M | $232.97M | $31.32M |
| Financing Cash Flow | $-423.93M | $-224.05M | $181.38M |
| Net Change in Cash | $-314.32M | $-163.08M | $287.10M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $83.26M | - | $253.86M | - |
| Cost of Revenue | $17.14M | - | $52.16M | - |
| Gross Profit | $66.12M | - | $201.70M | - |
| Operating Expenses | $63.75M | - | $200.90M | - |
| Research & Development | $14.02M | - | $46.84M | - |
| Operating Income | $2.37M | - | $801.00K | - |
| Interest Expense | - | - | $171.00K | - |
| Other Income/Expense | $376.00K | - | $-29.00K | - |
| Income Before Tax | $5.25M | - | $9.60M | - |
| Income Tax Expense | $3.72M | - | $5.03M | - |
| Net Income | $1.53M | $-33.97M | $4.58M | - |
| Basic EPS | 0.05 | - | 0.16 | - |
| Diluted EPS | 0.05 | - | 0.15 | - |
| Basic Shares Outstanding | $28.00M | - | $29.07M | - |
| Diluted Shares Outstanding | $29.38M | - | $31.00M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $223.30M | $349.28M |
| Accounts Receivable | $212.82M | $220.88M |
| Other Current Assets | $19.28M | $11.17M |
| Total Current Assets | $455.46M | $581.74M |
| Property Plant & Equipment | $19.58M | $1.95M |
| Other Non-current Assets | $962.00K | $794.00K |
| Total Assets | $569.43M | $678.43M |
| Accounts Payable | $15.31M | $7.16M |
| Accrued Liabilities | $16.72M | $17.96M |
| Other Current Liabilities | $1.54M | $6.09M |
| Total Current Liabilities | $206.53M | $204.16M |
| Total Liabilities | $239.82M | $221.15M |
| Retained Earnings | $-135.87M | $-140.45M |
| Total Stockholders Equity | $329.61M | $457.28M |
| Total Liabilities & Equity | $569.43M | $678.43M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $1.53M | $-33.97M | $4.58M | - |
| Depreciation & Amortization | - | - | $5.85M | - |
| Stock-based Compensation | - | - | $33.46M | - |
| Change in Receivables | - | - | $-6.14M | - |
| Change in Payables | - | - | $1.47M | - |
| Operating Cash Flow | - | - | $67.47M | - |
| Capital Expenditure | - | - | $12.77M | - |
| Investing Cash Flow | - | - | $-23.13M | - |
| Stock Repurchased | - | - | $178.18M | - |
| Financing Cash Flow | - | - | $-170.68M | - |
| Net Change in Cash | - | - | $-126.34M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.